MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma-Reference-Cited by-同舟云学术

MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma

Published:2014-11-24 Issue:12 Volume:136 Page:2844-2853
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Tuominen Rainer¹,Jewell Rosalyn²,van den Oord Joost J.³,Wolter Pascal³,Stierner Ulrika⁴,Lindholm Christer⁵,Hertzman Johansson Carolina¹,Lindén Diana¹,Johansson Hemming¹,Frostvik Stolt Marianne¹,Walker Christy²,Snowden Helen²,Newton-Bishop Julia²,Hansson Johan¹,Egyházi Brage Suzanne¹

Affiliation:

1. Department of Oncology and Pathology; Karolinska Institutet, Karolinska University Hospital; Stockholm Sweden

2. Leeds Institute of Cancer and Pathology, University of Leeds; Leeds United Kingdom

3. Department of General Medical Oncology; University Hospitals Leuven; Leuven Belgium

4. Department of Oncology; Sahlgrenska University Hospital; Gothenburg Sweden

5. Department of Oncology; Ryhov County Hospital; Jonkoping Sweden

Funder

Cancer Research UK

European Commission Directorate-General for Research and Innovation

Bramall Fellowship and a Medical Council Clinical Training Fellowship

Radiumhemmet Research Funds

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference36 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations;Flaherty;N Engl J Med,2012

3. Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond;Menzies;Eur J Cancer,2013

4. O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry;Christmann;Biochim Biophys Acta,2011

5. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J Clin Oncol,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies;Melanoma Research;2023-10-02

2. Identification and validation of three risk models in skin melanoma based on bioinformatics analysis;2023-04-18

3. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma;Frontiers in Endocrinology;2022-07-26

4. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications;Endocrine;2022-06-16

5. TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer;International Journal of Endocrinology;2022-06-15